Skip to content

Prospective surveillance of patients with developing chronic pulmonary thromboembolism and chronic thromboembolic pulmonary hypertension after occurring acute pulmonary thromboembolism

Prospective surveillance of patients with developing chronic pulmonary thromboembolism and chronic thromboembolic pulmonary hypertension after occurring acute pulmonary thromboembolism - Prospective surveillance of patients with developing chronic pulmonary thromboembolism and chronic thromboembolic pulmonary hypertension after occurring acute pulmonary thromboembolism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026437
Enrollment
100
Registered
2017-04-01
Start date
2017-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pulmonary thromboembolism

Interventions

None listed

Sponsors

Nagoya University Graduate School of Medicine, Department of Cardiology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patients with acute symptomatic pulmonary thromboembolism diagnosed by pulmonary arterial contrast enhanced CT, pulmonary angiography or ventilation/perfusion lung scan. 2) 16 years-old or older 3) obtained informed consent from patient

Exclusion criteria

Exclusion criteria: 1) contrast medium allergy 2) eGFR lower than 30 mL/min/1.73m2 3) pregnancy

Design outcomes

Primary

MeasureTime frame
The developing risk of chronic pulmonary thromboembolism and chronic thromboembolic pulmonary hypertension after one year ocurring acute pulmonary thromboembolism

Secondary

MeasureTime frame
1) developing risk of chronic pulmonary thromboembolism 2) developing risk of chronic thromboembolic pulmonary hypertension 3) recurrence of symptomatic acute pulmonary embolism 4)all cause death, cardiovascular death, non-cardiovascular death 5) incidence of bleeding 6) comparison of baseline characteristics 7) comparison among the treatments 8) trend of coagulation markers

Countries

Japan

Contacts

Public ContactYoshihisa Nakano

Nagoya University Graduate School of Medicine Department of Cardiology

okumura0607@med.nagoya-u.ac.jp+81-52-744-2150

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026